Home            Contact us            FAQs
    
      Journal Home      |      Aim & Scope     |     Author(s) Information      |      Editorial Board      |      MSP Download Statistics

     Asian Journal of Medical Sciences

    Abstract
2009(Vol.1, Issue:2)
Article Information:

Probable Cure of Two Patients With Advanced Gastric Carcinoma by Chemotherapy Only: Long-term Follow-up of a Phase I Trial With a Weekly Carboplatin and Epirubicin Regimen

E.J.M. Siemerink, G.A.P. Hospers, J.C. Berends, J.A. Gietema and N.H. Mulder
Corresponding Author:  Mulder 
Submitted: 2009 Month, 00
Accepted: 2009 July, 18
Published:
Abstract:
A dose escalation study of carboplatin in combination with 5FU and epirubicin in surgically incurable gastric cancer. Carboplatin was combined with a fixed dose epirubicin 35 mg/m2, leucovorin 250 mg/m2 and 5 FU 500 mg/m2 (CELF). The starting dose of carboplatin w as 100 mg/m2 which was escalated to 150 mg/m2. This CELF regimen was repeated every week, for a maximum of 14 cycles. Primary prophylaxis against leucopenia with filgastrim w as given. Twelve chemotherapy naive patients were enrolled, 9 w ith metastatic disease and 3 with locally advanced surgically irresectable disease. The major toxicities of the CELF regimen were uncomplicated leucopenia and thrombopenia. Nausea and mucositis were the most common nonhematological toxicities. The dose-limiting toxicity was grade 3 leucopenia, observed at a dose of 150 mg/m2/week. The objective response rate was 58% (95% CI 31%-85%). From the three patients with localized but surgically incurable disease two remain alive without disease progression and without sym ptoms after 6 and 9 years after chemotherapy without any other treatment.

Key words:  Stomach neoplasms, metastatic, chemotherapy, gastric, long-term survival, ,
Abstract PDF HTML
Cite this Reference:
E.J.M. Siemerink, G.A.P. Hospers, J.C. Berends, J.A. Gietema and N.H. Mulder, . Probable Cure of Two Patients With Advanced Gastric Carcinoma by Chemotherapy Only: Long-term Follow-up of a Phase I Trial With a Weekly Carboplatin and Epirubicin Regimen. Asian Journal of Medical Sciences, (2): Page No: 42-46.
ISSN (Online):  2040-8773
ISSN (Print):   2040-8765
Submit Manuscript
   Information
   Sales & Services
Home   |  Contact us   |  About us   |  Privacy Policy
Copyright © 2024. MAXWELL Scientific Publication Corp., All rights reserved